| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |